Current estimates indicate that 180 million individuals are infected with hepatitis C with more than half of these cases residing in the Asia Pacific region. By studying the entry, translation, replication and eventual release of virus, researchers have identified unique targets of antiviral therapy. The treatment of hepatitis C is evolving rapidly. Interferon free options are now finally available with impressive response rates. These options will be discussed in detail at the forthcoming APASL STC on hepatitis C to be held in Karachi, 17th to 19th October, 2014.
The conference will cover major developments surrounding the treatment of hepatitis C. Due to limited efficacy of interferon and ribavirin based regimens, directly acting antiviral drugs have been added to the make triple regimens. Interferon may not be indicated in special populations like patients with advanced cirrhosis and solid organ transplant patients. The meeting will discuss all oral interferon free regimens. Attention will be paid to discuss ‘difficult to treat’ patients and special populations by case vignettes, symposia and lectures. Preventive aspects of hepatitis C will be discussed in a symposium where leaders from WHO, World Hepatitis Alliance, CEVHAP and APASL will throw light on hepatitis control programs in the region and policy making according to the WHO four strategic axes. Postgraduate course on Day 1 will concentrate on diagnostics in the liver disease.
We look forward to your participation in this important event at Karachi, the most vibrant city and economic hub of Pakistan. The venue is located on the coast of the Arabian Sea, and provides outstanding facilities for accommodation and conference venues. There is always the opportunity to take in a round of golf on a course which is considered to be one of the prettiest in Pakistan, with stunning views of the sea. Please visit our website www.apaslstcpakistan2014.com.
APASL STC on HCV in Pakistan
Dates: October 17-19, 2014
City: Karachi, Pakistan
President: Dr. Zaigham Abbas
Message from Organizer
The Conference You Must Attend in 2014
This is the only few International Conference with the focus on viral hepatitis B in 2014.
The program will involve two tracks - Translational Medicine and Clinical Practice.
Over hundred top experts in the field will be invited to provide a high standard and comprehensive program.
Participants will also have a chance to have in-depth interaction with the editors of the major journals related to hepatology during the Special Course “Data Packaging and Publication: Asking the Editors” on 12 Dec.
Chance for Young Investigators in Asia Pacific Region
The abstract submission system was opened on 30 Apr 2014.
The oral and poster sessions will provide a chance to demonstrate your research findings to the world and ten young investigators will be chosen for “APASL Rising Star Presentation”.
Various awards and grants will be provided to encourage research and assist participants to attend the conference.
A Platform for Co-operation and Sharing
Guangzhou is the largest city in Southern China, it is an international hub that connecting China and the World.
We are expecting 2000 delegates from around the world attending this conference which is the excellent opportunity to link up Chinese doctors and the international colleagues.
With the huge patient database and numerous health workers in China, we believe there will be clinical cases that you will feel interested in but hardly find from other places.
If you are the one working in the field related to hepatology, you should not miss this conference. See you in Guangzhou this December!
Prof. Jinlin Hou
Chairman, APASL STC - 4th HBV Conference
APASL STC on HBV in China
Dates: December 12-14, 2014
City: Guangzhou, China
President: Dr. Jinlin Hou
APASL Future STCs in 2015
In 2015, we APASL will have following single topic conferences.
APASL STC on HCV in India
Date: August 21-23, 2015
City: New Delhi, India
Conference Patron: Dr. S K Sarin
Conference Chairman: Dr. B C Sharma
Conference Secretary: Dr. Manoj Kumar
Website: To be announced.
APASL STC on HBV in Armenia
Date: October 3-5, 2015
City: Yerevan, Armenia
Chairman: Dr. Hasmik Ghazinyan
Website: To be announced.
APASL Future Annual Meetings
2017 APASL Annual Meeting: City: Guangzhou, China
2018 APASL Annual Meeting: City: New Delhi, India
It is our pleasure to inform you that we have elected a 2014 fellow successfully and now we are in preparation phase to offer the fellow the best placement for pursuing his career.
The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2015 fellowship.
An application form can be downloaded by clicking here: http://www.apasl.info/applicationform-fellowship.docxPlease fill in and send to the APASL secretariat (firstname.lastname@example.org). We are looking forward to receiving your application.
There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL.
Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.
The EASL Special Conference: Optimal Management of Hepatitis B Virus Infection will be held on September 25-27, 2014 in Athens, Greece. For more information about the scientific program & registration process, please visit the official website at
For more information about related meetings, please visit the following URL in APASL official website; http://apasl.info/links-notices/related-meetings
If you have any useful information of related meetings, please let us know by sending email to email@example.com